IQVIA | pharmaphorum

Friday 5 December 2025

IQVIA

News

UCB_tower

UCB, Roche, and IQVIA take lead in UK life sciences investme...

Pharma giant UCB is to invest around £1 billion in the UK as part of a second life sciences sector deal with the UK government, with industry names such as Roche and IQVIA also committing t

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Debates & Insight

Simulacrum_webinar_holding_slide_16x9

Sponsored

Can simulated datasets unlock the potential of patient data?

Overview

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Market Access

Biotech-webinar-Image-16x9-Text

Sponsored

Realising the biotech promise: addressing the path to market

Overview Now more than ever before, biotech is the engine for innovation in medicine, finding, creating and delivering ground-breaking treatments to patients.

Partner Content

Viseven - omnichannel strategy

Partner Content

How to win at omnichannel

How to jump start your Digital Content Strategy

Partner Content

IQVIA Launches ePromo - a new Commercial Content Management Solution

Partner Content

IQVIA Launches ePromo - a new Commercial Content Management ...

Cloud-based solution accelerates and simplifies managing regulated promotional and non-promotional content for life sciences organizations

News

NICE1

Report warns of UK's rare disease 'postcode lottery'

There is still a ‘postcode lottery’ for patients getting access to vital rare disease treatments in the UK, according to a new report.